This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Ximmune Ab, Xmedic Ab. Active years: 2014-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2015
Title: Praveen Papareddy and His Biomedical Inventions
Introduction
Praveen Papareddy is an inventor based in Lund, Sweden. His patent work focuses on polypeptides with potential anti-inflammatory and anticoagulant applications. He is associated with Ximmune AB and Xmedic AB. The supplied information lists 2 patents.
Latest Patents
Heparin Cofactor II Fragments with Anti-Inflammatory and Anti-Coagulant Activity. This invention describes polypeptides based on heparin cofactor II, including fragments and variants, for potential use in treating or preventing inflammation and excessive blood coagulation. It also covers related nucleic acids, vectors, host cells, pharmaceutical compositions, and methods of use.
Polypeptides and Uses Thereof. This invention concerns polypeptides based on thrombin and related fragments or variants, with potential anti-inflammatory activity. The disclosed applications include treatment or prevention of inflammation and excessive blood coagulation, alongside related biological materials, pharmaceutical compositions, and methods of use.
Career Highlights
Papareddy’s listed inventions address biological mechanisms involved in inflammation and blood coagulation. His work includes proposed therapeutic uses for engineered polypeptides and related pharmaceutical approaches.
Collaborations
The supplied information identifies Martina Kalle and Artur Schmidtchen as Papareddy’s coworkers. It also lists Ximmune AB and Xmedic AB among the companies with which he has worked.
Conclusion
Praveen Papareddy’s patent portfolio centers on polypeptide-based approaches to inflammation and blood coagulation, reflecting a focus on potential biomedical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile